Organ Allocation : Organized by the Fondation Marcel Merieux and Universite Claude Bernard - Lyon 1 - Proceedings of the 30th International Conference on Transplantation and Clinical Immunology, 2-4 June 1998

Since the mid 1990s transplantation knowledge and techniques, as well as insights into pharmacology, have improved, thus enabling greater access to transplantation for patients. This book describes the management of waiting lists and the allocation of organs in transplantation.

Part 1: Overview of Organ Allocation Strategies in Different Countries. 1. Principles for Allocation of Cadaver Organs to Transplant Recipients and Coordinating Procedures in Spain; B. Miranda, J.M. González-Posada. 2. Principles and Practice of Cadaver Organ Allocation in France; C. Jacquelinet, D. Houssin. 3. Principles for Allocation of Cadaver Organs to Transplant Recipients in Italy; M. Cardillo, et al. 4. Allocation of Cadaver Organs to Transplant Recipients in Scandiatransplant; M. Madsen, et al. 5. Principles for Allocation of Cadaver Organs to Transplant Recipients in the USA (UNOS); W.W. Pfaff. 6. Allocation of Kidneys in the UK; P.M. Moriss, S. Fuggle. Part 2: Principles Underlying Current Policies in Organ Allocation. 7. What to Expect from a Good Kidney Allocation System; G. Opelz, T. Wujciak. 8. Allocation of Cadaver Organs to Transplant Recipients in Eurotransplant: Principles and Policies, Anno 1998; J. De Meester, G.G. Persijn. 9. Increasing Kidney Supply as the Best Solution to the Allocation Problem; P.I. Terasaki, et al. 10. Strategies in Organ Donation; R.A. Sells. 11. World Health Organization Guidelines on Transplantation and the WHO Task Force; B.M. Dickens. Part 3: Waiting List. 12. The French Liver Transplant Waiting List: 5-year Analysis (1992-1996); B. Suc. 13. Predictors of Multiple Listing for Cadaver Kidney Transplantation and the Effects of a Ban on Multiple Listing in the United States - A Summary; R. J. Ozminkowski, et al. 14. Allocation of Kidneys toPatients on the Transplant Waiting List: A Simulation-Based Policy Model; S.A. Zenios, et al. 15. Factors Influencing Early Placement on the Kidney Transplant Waiting List in the United States; B.L. Kasiske, et al. 16. The Organ Transplant Waiting List in France; P. Romano, et al. Part 4: At-Risk Donors. 17. Expanded Donor Pool; M. Manyalich, et al. 18. Non Heart-Beating Donors; P. Squifflet. 19. How to Reconcile Virological Safety and Efficacy in Organ Procurement; H. Agut. 20. Donors with Bacterial Infection in Organ Transplantation; A. Pahissa. 21. Further Readings on Allocation of Organs from At-Risk Donors; D. Forti. Part 5: Ischemia Reperfusion and Organ Allocation. 22. The Inflammatory Cascade of Liver Ischemia and Reperfusion: From the Donor to the Recipient; O. Le Moine, et al. 23. The Role of T-Cell Costimulatory Pathways in Ischemia-Reperfusion Injury; A. Chandraker, M.H. Sayegh. 24. Interest in an Anti-LFA-1 Monoclonal Antibody in the Prevention of Reperfusion Injury in Kidney Transplantation; M. Hourmant, J.P. Soulillou. 25. Preservation Solution in Heart Transplantation; P. Menasché. 26. The Impact of Ischemia-Reperfusion Injury on Specific and Non- Specific, Early and Late Chronic Events after Organ Transplantation; W. Land, K. Meßmer. 27. Pharmacological Intervention to Decrease Ischemia-Reperfusion Injury; J.M. Grinyó. Part 6: Living Donors and Organ Allocation. 28. Organ Transplantation in Islam; M.A. Mahmoud.